Ok Biotech Co., Ltd.(TW:4155)
NT$17.50-1.00 (-2.23%)
TW:4155
Ok Biotech Co., Ltd. financials statements
NT$17.50
At close:-1.00 (-2.23%)
Ok Biotech Co., Ltd. (4155) Ratios
Ok Biotech Co., Ltd. Ratios
TW:4155's free cash flow for Q2 2026 was NT$93.16M. For the 2026 fiscal year, TW:4155's free cash flow was decreased by NT$-33.77M and operating cash flow was NT$126.93M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.28 | 1.98 | 2.28 | 1.84 | 2.13 |
| Quick Ratio | 1.45 | 1.27 | 1.60 | 1.33 | 1.59 |
| Cash Ratio | 0.57 | 0.37 | 0.56 | 0.72 | 0.86 |
| Solvency Ratio | 0.14 | 0.15 | 0.12 | 0.17 | 0.08 |
| Operating Cash Flow Ratio | 0.58 | 0.09 | 0.01 | 0.29 | 0.03 |
| Short-Term Operating Cash Flow Coverage | 0.98 | 0.16 | 0.01 | 0.61 | 0.07 |
| Net Current Asset Value | NT$ -24.06M | NT$ 344.26M | NT$ 645.09M | NT$ 311.73M | NT$ 379.25M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.27 | 0.21 | 0.11 | 0.26 | 0.26 |
| Debt-to-Equity Ratio | 0.41 | 0.31 | 0.14 | 0.42 | 0.43 |
| Debt-to-Capital Ratio | 0.29 | 0.24 | 0.12 | 0.30 | 0.30 |
| Long-Term Debt-to-Capital Ratio | 0.19 | 0.11 | 0.04 | 0.17 | 0.19 |
| Financial Leverage Ratio | 1.53 | 1.48 | 1.28 | 1.66 | 1.65 |
| Debt Service Coverage Ratio | 0.58 | 0.43 | 0.32 | 0.52 | 0.21 |
| Interest Coverage Ratio | 9.88 | 9.18 | -1.34 | 18.52 | 6.11 |
| Debt to Market Cap | 0.34 | 0.23 | 0.09 | 0.27 | 0.30 |
| Interest Debt Per Share | 6.24 | 5.51 | 2.67 | 7.42 | 7.02 |
| Net Debt to EBITDA | 3.57 | 2.44 | 0.11 | 0.74 | 1.59 |
| Profitability Margins | |||||
| Gross Profit Margin | 27.58% | 16.51% | 16.52% | 23.25% | 14.79% |
| EBIT Margin | 6.93% | 7.98% | 0.98% | 12.61% | 4.29% |
| EBITDA Margin | 12.95% | 12.32% | 7.32% | 16.68% | 6.76% |
| Operating Profit Margin | 6.93% | 3.43% | -1.01% | 14.26% | 3.90% |
| Pretax Profit Margin | 6.67% | 7.61% | 0.67% | 11.84% | 3.65% |
| Net Profit Margin | 5.30% | 5.63% | 0.25% | 9.67% | 2.49% |
| Continuous Operations Profit Margin | 6.24% | 6.37% | -0.58% | 8.72% | 0.54% |
| Net Income Per EBT | 79.38% | 73.93% | 36.73% | 81.70% | 68.10% |
| EBT Per EBIT | 96.27% | 222.17% | -66.54% | 82.97% | 93.57% |
| Return on Assets (ROA) | 2.14% | 2.54% | 0.10% | 4.69% | 1.12% |
| Return on Equity (ROE) | 3.28% | 3.77% | 0.12% | 7.78% | 1.84% |
| Return on Capital Employed (ROCE) | 3.27% | 1.94% | -0.48% | 9.48% | 2.33% |
| Return on Invested Capital (ROIC) | 2.77% | 1.42% | 0.09% | 6.27% | 1.37% |
| Return on Tangible Assets | 2.44% | 2.92% | 0.10% | 4.74% | 1.14% |
| Earnings Yield | 3.04% | 2.89% | 0.08% | 4.93% | 1.28% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.80 | 2.92 | 2.44 | 3.62 | 3.12 |
| Payables Turnover | 9.68 | 7.14 | 5.00 | 4.65 | 4.51 |
| Inventory Turnover | 2.47 | 2.63 | 2.53 | 2.69 | 2.87 |
| Fixed Asset Turnover | 0.77 | 1.03 | 1.38 | 1.70 | 1.92 |
| Asset Turnover | 0.40 | 0.45 | 0.39 | 0.48 | 0.45 |
| Working Capital Turnover Ratio | 2.18 | 2.28 | 1.66 | 2.00 | 1.79 |
| Cash Conversion Cycle | 206.09 | 212.64 | 221.11 | 157.91 | 163.47 |
| Days of Sales Outstanding | 96.12 | 124.91 | 149.61 | 100.75 | 116.98 |
| Days of Inventory Outstanding | 147.68 | 138.88 | 144.53 | 135.59 | 127.36 |
| Days of Payables Outstanding | 37.71 | 51.15 | 73.03 | 78.42 | 80.87 |
| Operating Cycle | 243.80 | 263.79 | 294.15 | 236.33 | 244.34 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.91 | 0.46 | 0.02 | 2.25 | 0.21 |
| Free Cash Flow Per Share | -0.53 | -2.17 | -3.39 | -0.50 | -0.61 |
| Dividend Paid and CapEx Coverage Ratio | 0.71 | 0.16 | 0.01 | 0.62 | 0.10 |
| Capital Expenditure Coverage Ratio | 0.78 | 0.18 | 0.01 | 0.82 | 0.25 |
| Operating Cash Flow Coverage Ratio | 0.31 | 0.08 | 0.01 | 0.31 | 0.03 |
| Operating Cash Flow to Sales Ratio | 0.21 | 0.04 | 0.00 | 0.16 | 0.02 |
| Free Cash Flow Yield | -3.31% | -9.49% | -12.09% | -1.85% | -2.64% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 27.90 | 34.58 | 1217.39 | 20.34 | 77.00 |
| Price-to-Sales (P/S) Ratio | 1.74 | 1.95 | 3.01 | 1.96 | 1.94 |
| Price-to-Book (P/B) Ratio | 1.08 | 1.31 | 1.50 | 1.58 | 1.44 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -30.25 | -10.54 | -8.27 | -54.14 | -37.89 |
| Price-to-Operating Cash Flow Ratio | 8.48 | 49.37 | 1224.22 | 12.09 | 111.72 |
| Price-to-Earnings Growth (PEG) Ratio | -2.30 | 0.01 | -12.39 | 0.06 | -0.98 |
| Enterprise Value Multiple | 17.02 | 18.25 | 41.27 | 12.50 | 30.22 |
| Enterprise Value | 3.43B | 3.76B | 3.60B | 3.09B | 2.58B |
| EV to EBITDA | 17.02 | 18.25 | 41.27 | 12.50 | 30.22 |
| EV to Sales | 2.20 | 2.25 | 3.02 | 2.08 | 2.04 |
| EV to Free Cash Flow | -38.28 | -12.16 | -8.29 | -57.57 | -39.99 |
| EV to Operating Cash Flow | 10.73 | 56.99 | 1227.61 | 12.86 | 117.93 |
| Tangible Book Value Per Share | 12.61 | 14.65 | 18.48 | 17.00 | 15.65 |
| Shareholders’ Equity Per Share | 15.01 | 17.48 | 18.70 | 17.29 | 16.10 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.06 | 0.16 | 1.20 | 0.22 | 0.32 |
| Revenue Per Share | 9.29 | 11.71 | 9.30 | 13.91 | 11.93 |
| Net Income Per Share | 0.49 | 0.66 | 0.02 | 1.34 | 0.30 |
| Tax Burden | 0.79 | 0.74 | 0.37 | 0.82 | 0.68 |
| Interest Burden | 0.96 | 0.95 | 0.69 | 0.94 | 0.85 |
| Research & Development to Revenue | 0.04 | 0.03 | 0.04 | 0.03 | 0.02 |
| SG&A to Revenue | 0.16 | 0.11 | 0.12 | 0.11 | 0.12 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Income Quality | 3.88 | 0.52 | 0.37 | 1.37 | 0.47 |
Currency in TWD
